BIP
IOVA icon

Brandes Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Brandes Investment Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17,600
Closed -$161K – 189
2015
Q2 		$161K Hold
17,600
– – ﹤0.01% 156
2015
Q1 		$213K Buy
+17,600
New +$198K ﹤0.01% 142

Other funds holding IOVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Brandes Investment Partners's IOVA Position: Q3 2015 in Review

Brandes Investment Partners sold out of Iovance Biotherapeutics (IOVA) in Q3 2015, closing a stake of 17,600 shares — an estimated $161K sold.

Brandes Investment Partners first reported a position in IOVA in Q1 2015 and held it in 2 quarters. The position peaked at $213K in Q1 2015. 80 funds tracked by Wall St. Rank hold IOVA as of Q3 2015.

  • Brandes Investment Partners reported no remaining Iovance Biotherapeutics position as of Q3 2015 after selling out during the quarter.
  • Brandes Investment Partners sold 17,600 Iovance Biotherapeutics shares in Q3 2015, an estimated $161K.
  • Brandes Investment Partners first reported a position in Iovance Biotherapeutics in Q1 2015 and held it in 2 quarters.
  • Brandes Investment Partners's Iovance Biotherapeutics position peaked at $213K in Q1 2015.
  • 80 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2015.

Based on Brandes Investment Partners's 13F filing for Q3 2015, filed 6 Nov 2015.